Invention Grant
- Patent Title: Modified Fc gamma receptor type III (FcgammaIII, HNA-1) polypeptides and the uses thereof
-
Application No.: US16783156Application Date: 2020-02-05
-
Publication No.: US11460470B2Publication Date: 2022-10-04
- Inventor: Jar-How Lee , Neng Jen Remi Shih , Julie Nguyen , Rui Pei
- Applicant: ONE LAMBDA, INC.
- Applicant Address: US CA West Hills
- Assignee: ONE LAMBDA, INC.
- Current Assignee: ONE LAMBDA, INC.
- Current Assignee Address: US CA West Hills
- Agency: BakerHostetler
- Main IPC: C12P21/04
- IPC: C12P21/04 ; G01N33/566 ; G01N33/564 ; C07K14/735 ; C07K1/00
Abstract:
The invention is directed to engineered Fc gamma receptor type III (FcγII, HNA-1) polypeptides and use of these polypeptides to detect antibodies specific for human neutrophil antigens (HNA). The invention is also directed to methods for the diagnosing and determining susceptibility for developing Transfusion Reaction Acute Lung (TRALI).
Public/Granted literature
- US20200319179A1 Modified Fc Gamma Receptor Type III (FcgammaIII, HNA-1) Polypeptides and The Uses Thereof Public/Granted day:2020-10-08
Information query
